Citations

Mayo Clinic

Clear

88160 citation(s) found for "NA".

Developmental genetic determinants of the human cerebrospinal fluid–ventricular system
Allington, Garrett , Dennis, Evan , Li, Qiang , McGee, Stephen , Mekbib, Kedous Y., Hatada, Izuho , Weston, Matthew C. , Shore, Amy N., Cullen, Erin R. , Singh, Amrita , Miyagishima, Danielle , Kiziltug, Emre, Hale, Andrew T. , Fan, Baojian , Nelson-Williams, Carol, Moreno-De-Luca, Andrés , Kasper, Ekkehard M. , Smith, H M, Davalan, William C., Kundishora, Adam J. , Luikart, Bryan W. , Haider, Shozeb , Alper, Seth L. , Lifton, Richard P. , Jin, Sheng Chih , Kahle, Kristopher T. , Weston, Matthew C , Shore, Amy N , Cullen, Erin R , Miyagishima, Danielle , Hale, Andrew T , Fan, Baojian , Moreno-de-Luca, Andrés , Kasper, Ekkehard M , Kundishora, Adam J , Luikart, Bryan W , Haider, Shozeb , Alper, Seth L , Lifton, Richard P , Jin, Sheng Chih , Kahle, Kristopher T , Mehta, Neel H. , Mekbib, Kedous Y. , DeSpenza, Tyrone , Duy, Phan Q. , Nelson‐Williams, Carol

Science Translational Medicine | July 8, 2026 | Volume: 18 | Issue: 857 | Pages: No page available

10.1126/scitranslmed.aec4386 | PMID 42418557 Get It

Primary enlargement of the cerebrospinal fluid (CSF)–filled brain ventricles, known as congenital cerebral ventriculomegaly (CCV), is a hallmark of congenital hydrocephalus. CCV is also enigmatically but frequently associated with autism and other neurodevelopmental disorders. To gain insight into the developmental genetic regulation of the human CSF-ventricular system, we conducted an integrated, multiomic study of about 2700 trio-based exomes from patients with primary CCV. We found that about 25% of cases were associated with rare, damaging de novo variants in mutation-intolerant genes, many of which are linked to other dominant Mendelian disorders. Thirty-five exome-wide significant CCV genes and dozens of other high-confidence CCV genes converged on pathways involved in ATP-dependent Brahma-related gene 1/Brahma-associated factor chromatin remodeling, histone H3 lysine 4 methylation, and phosphoinositide 3-kinase signaling. Knockout of selected CCV genes in mouse models supported that de novo variants in CCV genes caused ventriculomegaly by impairing both CSF dynamics and cortical cytoarchitecture through dysregulation of neuroprogenitor cell growth and maturation in the ventricular and subventricular zones. These findings indicated that genetic and epigenetic programs coordinate the “hand-in-glove” development of the CSF-ventricular system with that of the cerebral cortex and establish a genetic connection between CCV and neurodevelopmental disorders, potentially explaining why some patients with hydrocephalus continue to exhibit CCV and neurodevelopmental disorders despite CSF shunting. We suggest that combined brain imaging and whole-exome sequencing could enable early detection of, and intervention for, autism and other neurodevelopmental disorders.
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma
Nayab, Arifa , Mughal, Nouman , Angez, Meher , Xing, Sansi, Burma, Aarohan M. , Balla, Harshitha, Kizilbash, Sani H. , Yang, Xiaoyao , Maqbool, Muhammad Asad , Arain, Fazal Manzoor , Hussain, Azhar , Amir, Sahara , Singh, Deepti , Karmali, Alyiah , Somani, Saif, Patel, Toral , Patel, Ankur, Hatanpaa, Kimmo J. , YOUSSEF, M. S. K. , Shaikh, Nawal , Ye, C., Burma, Sandeep , Sarkaria, Jann N. , Majd, Nazanin , Saleh, Mansoor, Charest, Alain , Miller, C Ryan, Nabors, Burt , Kataru, Mary Susmitha , Tolbert, Chandler E. , Jimenez, Fatima, Enam, Syed Ather , Habib, Amyn A. , Guo, Gao , Arain, Fazal , Patel, Toral R , Youssef, Michael , Zhao, Dawen , Burma, Sandeep , Sarkaria, Jann N , Majd, Nazanin K , Charest, Alain , Nabors, Louis Burt , Kataru, Mary Susmitha , Tolbert, Chandler E , Enam, Syed Ather , Habib, Amyn A , Guo, Gao , Kizilbash, Sani H , Burma, Aarohan M , Amir, Sahara , Somani, Saif, Zhao, Dawen

Science Translational Medicine | July 8, 2026 | Volume: 18 | Issue: 857 | Pages: No page available

10.1126/scitranslmed.adx8398 | PMID 42418561 Get It

Glioblastoma (GBM) is a devastating cancer with a dismal prognosis. Current treatment includes temozolomide (TMZ), which is more effective in about 50% of GBMs that have O 6 - methylguanine DNA methyltransferase ( MGMT ) promoter methylation. MGMT is a DNA repair protein that reverses TMZ-induced DNA damage. EGFR is a prime oncogene in GBM. Here, we report that EGFR inhibition induced the down-regulation of MGMT in GBM cells, revealing a previously unidentified link between EGFR signaling and response to TMZ. EGFR inhibition led to activation of two transcription factors, activator protein-1 (AP-1), which repressed MGMT transcription, and nuclear factor κB (NF-κB), which up-regulated MGMT transcription. EGFR inhibition also induced AP-1–mediated transcription of miR-616. miR-616 inhibited both MGMT translation and NF-κB activation. Thus, the overall effect of EGFR inhibition was down-regulation of MGMT expression. In addition, we provided an explanation for the prior failure of clinical trials that used concomitant EGFR tyrosine kinase inhibitors (TKIs) and TMZ. TMZ up-regulated MGMT, and concomitant treatment with EGFR TKIs and TMZ failed to down-regulate MGMT. However, pretreatment with EGFR TKIs followed by TMZ efficiently down-regulated MGMT and enhanced TMZ sensitivity in experimental models. Posttreatment tumor tissues from two clinical trials were used to validate these findings. We demonstrated that EGFR inhibitors induced down-regulation of MGMT in posttreatment resected tumor tissues from patients with GBM and the failure of EGFR inhibition to down-regulate MGMT if TMZ was used concomitantly. These data support using EGFR TKIs before TMZ treatment as a therapeutic approach in MGMT unmethylated GBM.
Urinary CD4 + Effector Memory CD38 + HLA-DR + T Cells for Diagnosis of Acute Interstitial Nephritis
Sha, Wenxin , Mirkheshti, Pouneh , Shi, Feng, Skopnik, Christopher Mark , Russ, Jeremy, Daniel, C, Amann, K, Arzig, Joram, Goerlich, Nina , Chen, Jianghua, Eckardt, Kai-Uwe, Jiang, Hong, Enghard, Philipp , Herrmann, Sandra M. , Klocke, Jan , Eckardt, Kai-Uwe , Jiang, Hong

No container title available | July 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.25.26356554 Get It

Abstract Introduction Acute interstitial nephritis is an important differential diagnosis in patients with deteriorating kidney function. Diagnosis currently requires kidney biopsy, an invasive procedure associated with risks. We hypothesized that urinary T cells may serve as a non-invasive biomarker for acute interstitial nephritis. Methods A total of 320 patients undergoing clinically indicated kidney biopsy were enrolled in a discovery cohort at Charité Berlin (n = 80), an internal validation cohort at Charité (n = 100), and an external validation cohort at The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou (n = 140). Urinary immune cells were assessed by flow cytometry. Renal T cell infiltration was evaluated by immunofluorescence in kidney biopsy specimens from the discovery and internal validation cohorts, including 16 patients with acute interstitial nephritis and 9 patients without acute interstitial nephritis. Additionally, CXCL9 was measured by ELISA in 102 urine samples from these cohorts. Results Across all cohorts, 27 patients (8.4%) were diagnosed with acute interstitial nephritis. In the discovery cohort, multiple urinary T cell subsets were increased in acute interstitial nephritis, with activated CD4 + effector memory T cells expressing CD38 and HLA-DR showing the strongest diagnostic performance. This marker outperformed urinary monocytes, eosinophils, and CXCL9 and was validated in both independent cohorts. Across all cohorts, the area under the receiver operating characteristic curve was 0.84 and increased to 0.91 after exclusion of 8 patients receiving corticosteroids. A cutoff of 211 activated CD4 + effector memory T cells per 100 mL urine yielded a sensitivity of 78% and a specificity of 81%. Urinary activated CD4 + effector memory T cell counts correlated with renal CD4 + and CD4 + CD38 + T cell infiltration in acute interstitial nephritis. Conclusions Urinary activated CD4 + effector memory T cells expressing CD38 and HLA-DR represent a promising non-invasive biomarker for the diagnosis of acute interstitial nephritis. Lay Summary Acute interstitial nephritis is a frequent cause of acute kidney injury and is usually diagnosed by kidney biopsy, an invasive procedure that carries risks. We investigated whether immune cells in urine could help identify AIN in a less invasive manner. In this multicenter study, urine samples from 320 patients undergoing kidney biopsy in Germany and China were analyzed. We found that a specific population of activated T cells was markedly increased in the urine of patients with AIN compared with patients with other kidney diseases. This urinary marker outperformed other immune cell types and the inflammatory cytokine CXCL9 and was successfully validated in independent cohorts from both Germany and China. Importantly, urinary activated T cell counts correlated with immune cell infiltration within the kidney. These findings suggest that urinary activated T cells may serve as a non-invasive biomarker to support the diagnosis of AIN and facilitate earlier clinical decision-making.
AI‐surrogate structure and dose correlation for left anterior descending artery in lung stereotactic body radiotherapy
Chang, Grace, Chen, Quan, Zhu, Libing, Rong, Yi, Yu, Nathan Y., Tao, Randa , Zhu, Libing, Yu, Nathan Y.

Journal of Applied Clinical Medical Physics | July 8, 2026 | Volume: 27 | Issue: 7 | Pages: No page available

10.1002/acm2.70703 | PMID 42418215 Get It

Abstract Background The left anterior descending (LAD) coronary artery is a critical organ‐at‐risk in thoracic radiotherapy. In thoracic stereotactic body radiation therapy (SBRT), sharp dose gradients and poor LAD contrast on 4DCT scans introduce uncertainty in LAD dose assessment. Methods We evaluated the performance of an AI‐generated LAD region structure as a surrogate for manual LAD contours in early‐stage NSCLC. We used deep inspiration breath hold (DIBH) scans from 49 patients with manually delineated LADs; planning risk volume contours were expanded by 3 mm. Then, 96 lung SBRT dose maps were registered by matching the left anterior portion of the heart contours. Dice similarity coefficient (DSC), inclusion ratios (IR), dose–volume histogram (DVH) metrics, linear regression, and linear mixed models were used to compare the structures. The correlation of the AI LAD region and LAD dose to mean heart dose (MHD) was assessed. Results The AI LAD region showed strong correlation with manual LAD contours for maximum dose (D1%, R 2 = 0.93) and volume receiving ≥10 Gy (V10Gy, R 2 = 0.81). The planning risk volume also demonstrated high correlation to the AI LAD region. MHD was a poor predictor of LAD dose ( R 2 ≈0.4). Additional dose metric correlations were assessed. Discussion To investigate dose volume effects to the LAD during radiotherapy for stage I NSCLC, a robust segmentation paradigm must be established. It must be easily implementable on typical imaging acquired during treatment, with an emphasis on clinical translatability. Our model has shown that the AI LAD region has a strong correlation with LAD dose under typical lung SBRT doses and supports its use for further investigation into LAD dose volume constraints during lung SBRT. Conclusion AI LAD region provides a clinically feasible and scalable alternative to manual LAD contouring for dose estimation in lung SBRT. Its strong correlation with key dose metrics validates its use in large‐scale retrospective and prospective studies.
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma
Kassamali, Bina , Schoenfeld, Jonathan D., Sethi, Rosh, Bakst, R H, Barker, C. A., Bradford, Carol R., Carr, David R., Chandra, Sunandana , Connolly, Karen L., Demer, Addison M. , Doonan, Bently, Emerick, Kevin, Friedman, Ben J. , Gali, Linna L., Galloway, Thomas J., Geiger, Jessica L., Kohen, Laurie, Koyfman, Shlomo, Kumar, Shweta Sharat, Learned, Kim O. , Leitenberger, Justin J., Lilley, Elizabeth J. , Lukens, John N. , Medina, Theresa , Mitra, Devarati , Ozog, David, Pashtan, Itai, Pham, Nancy , Powers, Molly, Srivastava, Divya, Taylor, Charlotte S., Witek, Matthew E. , Wysong, Ashley, Zander, David, Silk, Ann W., Jambusaria-Pahlajani, Anokhi, Ruiz, Emily S., Chen, Michelle , Kumar, Shweta S. , Schoenfeld, Jonathan D. , Barker, Christopher A. , Bhatt, Alok A. , Bradford, Carol R. , Bunch, Paul M. , Carr, David R., Carucci, John A. , Chen, Michelle , Connolly, Karen , Doonan, Bently P. , Emerick, Kevin S. , Friedman, Ben J. , Galloway, Thomas J. , Guenette, Jeffrey P. , Kelly, Hillary R. , Khushalani, Nikhil I. , Kohen, Laurie Linden, Leitenberger, Justin J. , Medina, Theresa M. , Pashtan, Itai , Patel, Vishal Anil , Srivastava, Divya , Swiecicki, Paul Loren , Wysong, Ashley, Silk, Ann Willman , Jambusaria‐Pahlajani, Anokhi , Ruiz, Emily S.

JAMA Dermatology | July 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1001/jamadermatol.2026.2163 | PMID 42418212 Get It

Importance There is no consensus on staging and surveillance imaging for cutaneous squamous cell carcinoma (CSCC). Although imaging has been shown to affect management, broad recommendations from the National Comprehensive Cancer Network have led to variability in clinical practice. Objective To develop multidisciplinary consensus recommendations on the use of staging and surveillance imaging of localized CSCC. Evidence Review A multidisciplinary expert panel across academic and clinical practice settings convened a Delphi consensus, with 3 iterative survey rounds from January to June 2025. Data were analyzed from February 2025 to January 2026. Eligibility defined by at least 1 to 2 CSCC publications during the previous 5 years, involvement in a relevant clinical trial, experience treating at least 3 patients monthly with CSCC, and/or 5 years or longer of clinical practice. Fifty-four experts were invited and 45 (83%) completed all 3 rounds and were included in the final analysis. Structured Delphi surveys evaluated clinical scenarios, imaging modalities, and surveillance strategies for CSCC. Consensus and near-consensus recommendations were generated, defined as 80% or greater and 70% to 79% agreement, respectively. Findings The 45 participants (21 female individuals [47%] and 24 male individuals [53%]; 14 Asian individuals [31%], 1 multiracial individual [2%], and 30 White individuals [67%]) consisted of dermatology (15 [33%]), medical oncology (7 [16%]), radiation oncology (9 [20%]), radiology (9 [20%]), surgery (3 [7%]), and otolaryngology specialists (2 [4%]). The Delphi panel recommended staging and surveillance for CSCCs with at least a 15% risk of metastasis. Consensus or near consensus was reached to recommend staging and surveillance imaging for tumors with a concern for metastasis, bone invasion, invasion beyond subcutaneous fat, large-caliber nerve invasion, or a diameter of 4 cm or larger or the combination of tumors with poorly differentiated histology and any of the following: diameter of 2 cm or larger, lymphovascular invasion and subcutaneous fat invasion, or lymphovascular invasion and small-caliber perineural invasion. Computed tomography imaging was the preferred modality for nodal staging (38 [84%]) and surveillance (35 [78%]). For surveillance duration, consensus was reached to provide imaging for at least 2 years, and near consensus was reached for at least 3 years. Conclusions and Relevance This study provides an expert consensus–based framework to standardize imaging in localized CSCC that may inform future guidelines.
Evaluating the role of youth-onset diabetes mellitus in the context of food insecurity and preventive care: a repeated cross-sectional study using propensity score weighted machine learning analysis
Lee, Yu-Sheng , Stetson, Raymond C. , Hollender, Heaven, Sprong, Matthew E. , Huang, Xueli, Kumar, Karan, Joshi, Urja Nimitkumar, Lee, Yu-Sheng , Hollender, Heaven

BMJ Paediatrics Open | July 8, 2026 | Volume: 10 | Issue: 1 | Pages: e003792

10.1136/bmjpo-2025-003792 | PMID 42419911 Get It

Background Youth-onset diabetes mellitus (DM) is an increasing public health concern, especially among adolescents facing socioeconomic challenges. Food insecurity (FI), a key social determinant of health, has been linked to adverse metabolic outcomes, but its association with youth-onset DM and the role of preventive care remain unclear. Methods Using repeated cross-sectional data from the National Survey of Children’s Health (2016–2021), we examined the association between FI status (food secure, mild FI and moderate-to-severe FI) and youth-onset DM among adolescents aged 10–17 years. We also evaluated whether usual preventive care modified this association. Propensity score weighting (PSW) was used to reduce the imbalance of measured confounders across FI groups. These weights were applied in the least absolute shrinkage and selection operator logistic regression for variable selection and in the final multivariable logistic regression models. Results In the PSW analysis of 66 560 adolescents, 432 had youth-onset DM. Moderate-to-severe FI was associated with higher odds of DM than food-secure adolescents (OR 1.55, 95% CI 1.35 to 1.77; p<0.0001), whereas mild FI was not associated with youth-onset DM. Among adolescents with preventive care visits, both mild FI (OR 1.19, 95% CI 1.04 to 1.37; p=0.0126) and moderate-to-severe FI (OR 1.67, 95% CI 1.46 to 1.92; p<0.0001) were associated with higher odds of DM. Among those without preventive care visits, FI was associated with lower odds of having a reported DM diagnosis, especially in the moderate-to-severe FI group (OR 0.11, 95% CI 0.03 to 0.35; p=0.0002). Conclusions Moderate-to-severe FI was associated with youth-onset DM, and this relationship varied by access to preventive care. Adolescents with FI who lack regular preventive care may have fewer opportunities for DM diagnosis. Public health strategies should integrate FI screening, equitable access to preventive services and culturally responsive approaches to chronic disease prevention.
Extreme Heterogeneity Reported in Published Anatomical Meta‐Analyses: A Meta‐Epidemiological Study
IWANAGA, Joe, Walocha, Jerzy, Ottone, Nicolás Ernesto , Loukas, Marios , Tubbs, R. Shane, Ottone, Nicolás E , Iwanaga, Joe , Walocha, Jerzy Andrzej

Clinical Anatomy | July 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ca.70180 | PMID 42417541 Get It

ABSTRACT Following the introduction of meta‐analytic methodology into anatomical research, anatomical meta‐analyses have increased substantially. However, extremely high statistical heterogeneity is frequently observed in these studies, while its implications remain insufficiently discussed within anatomical research. The present study investigated the current state and patterns of heterogeneity in anatomical meta‐analyses and explored the interpretive implications of heterogeneity in anatomical evidence synthesis. A PubMed search was performed on May 21, 2026, using the title‐based search strategy: ((meta‐analysis[Title]) OR (meta analysis[Title])) AND (anatomy[Title]). Anatomical meta‐analyses focused on human structural anatomy were included. Reported I 2 values were extracted and descriptively analyzed by overall distribution and anatomical category. A total of 132 studies were identified, of which 61 anatomical meta‐analyses with analyzable heterogeneity data were included. The mean reported I 2 value was 95.27% (range 41%–100%), with a median I 2 of 98.77%. Most studies demonstrated extreme heterogeneity, with 86.9% reporting I 2 values exceeding 90%. Category‐specific analysis demonstrated consistently elevated heterogeneity across anatomical systems, including skeletal structures (mean I 2 = 99%), peripheral nerves (mean I 2 = 95%), and vascular anatomy studies (mean I 2 = 94.56%). Despite this, pooled prevalence estimates were frequently reported with highly precise numerical values and narrow confidence intervals. Extreme statistical heterogeneity is highly prevalent across anatomical meta‐analyses and appears to represent a widespread characteristic of anatomical synthesis research rather than an isolated statistical phenomenon. Although such heterogeneity likely reflects genuine biological and methodological variability, pooled anatomical estimates should be interpreted with caution, particularly when highly precise numerical estimates are reported despite substantial interstudy inconsistency. These findings highlight the importance of transparent heterogeneity reporting and anatomically stratified approaches in future anatomical meta‐analyses.
Deep Learning-Based Deblurring for Computed Tomography and a Phantom Evaluation for Coronary Artery Calcium Detectability
Werf, Niels R. van der , Huber, Nathan R., Leiner, Tim , Wuelker, Christian, Schnellbaecher, Nikolas D., Greuter, Marcel J.W. , Graß, Michael , Leiner, Tim , Huber, Nathan R. , Suchá, Dominika , Wülker, Christian , Schnellbächer, Nikolas D.

Journal of Computer Assisted Tomography | July 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/rct.0000000000001897 | PMID 42417480 Get It

Introduction: This study aimed to develop and evaluate a deep learning (DL) deblurring algorithm for computed tomography (CT). Phantom testing assessed whether DL deblurring could improve CT image quality and coronary artery calcium (CAC) detectability. Materials and Methods: The algorithm consisted of 2 sequential convolutional neural networks (CNNs): one for denoising and one for deblurring. After deblurring, the estimated noise from the first model was reintroduced to preserve image texture. The CNN denoising model was trained to map high-noise images to routine low-noise ones. The CNN deblurring model was trained using natural images—blurred inputs paired with sharp targets. To assess performance, an anthropomorphic phantom with 100 small calcifications was scanned on a CT system using a CAC scoring protocol. Data were acquired at clinical and high doses, then reconstructed with and without DL deblurring, using 25% of the maximum denoising strength. Detectability was defined as the ability to calculate an Agatston score (≥3 adjacent voxels >130 HU). Results: At high dose, CAC detectability increased from 39% (standard reconstruction) to 48% with deblurring. Similar detectability (39%) was achieved at the routine dose with deblurring, representing a 6% improvement compared with the original routine dose data. Discussion: Quantitative results from phantom testing demonstrate that DL deblurring can improve image quality, based on a clinically relevant, task-based CAC detection metric at clinical dose levels.
Incidental Multisystem Anomalies in an Adolescent Female: A Case Report of a Diagnostic Dilemma
Alla, Deekshitha , Chanti, Pranathi, Khetan, Moksh Sanjay, Appala, Srinidhi , Dugyala, Rohit Rao , Roy, Sagnik , Chittepu, Keerthana, Mohanta, Pritha, Bollampalli, Ram Prasanjith Reddy, Bayeh, Ruth Getaneh , Khetan, Moksh Sanjay

Clinical Medicine Insights: Case Reports | July 8, 2026 | Volume: 19 | Issue: No issue available | Pages: No page available

10.1177/11795476261467685 | PMID 42428543 Get It

Background Congenital anomalies of the urogenital system frequently coexist with renal abnormalities due to their shared origin from the intermediate mesoderm. Skeletal anomalies may also be associated, reflecting overlapping embryological development of mesodermal derivatives. Such multisystem involvement can pose a diagnostic challenge, particularly when identified incidentally. Case Presentation We report a 15-year-old female who presented with abdominal swelling and pain, later diagnosed as an umbilical hernia. During radiological evaluation, incidental findings of right renal agenesis, scoliosis, and a bicornuate uterus were identified. The patient underwent successful surgical management of the umbilical hernia. This case highlights the importance of recognizing coexisting anomalies and adopting an integrated approach in evaluation and management. Conclusion This case highlights the need for a systematic, bidirectional evaluation when a congenital anomaly is identified, particularly involving the renal, genital, and skeletal systems. A syndromic perspective is essential to avoid missed diagnoses, facilitate appropriate follow-up, and anticipate long-term implications in such patients.